FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

764772008: Prolonged-release vaginal ring (dose form)

Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3655023014 Prolonged-release vaginal ring en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3655024015 Prolonged-release vaginal ring (dose form) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Prolonged-release vaginal ring Is a Vaginal dose form (dose form) true Inferred relationship Some
Prolonged-release vaginal ring Has dose form administration method (attribute) A method of administration of a dose form by being placed into a body cavity. true Inferred relationship Some
Prolonged-release vaginal ring Has dose form transformation (attribute) No transformation true Inferred relationship Some
Prolonged-release vaginal ring Dose form intended site describes the general anatomic location that the dose form has been formulated for administration to or at. The intended site is not intended to describe a precise site or route of administration. For example, eye drops (prepared for ocular intended site) are subject to pharmacopoeial standards for pH, and sterility. An intended site for a dose form that is for administration to the vagina. true Inferred relationship Some
Prolonged-release vaginal ring Has dose form release characteristic (attribute) A release characteristic where a dose form displays a slower release of the active substance(s) than that of a conventional-release dose form. This may be achieved by a special formulation design, manufacturing process or other methods. true Inferred relationship Some
Prolonged-release vaginal ring Has basic dose form (attribute) Ring true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing precisely estradiol 2.083 microgram/1 hour prolonged-release vaginal ring (clinical drug) Has manufactured dose form True Prolonged-release vaginal ring Inferred relationship Some
Estradiol 4.167 microgram/hour prolonged-release vaginal ring Has manufactured dose form True Prolonged-release vaginal ring Inferred relationship Some
Product containing precisely estradiol 312.5 nanogram/1 hour prolonged-release vaginal ring (clinical drug) Has manufactured dose form True Prolonged-release vaginal ring Inferred relationship Some
Progesterone 416.667 microgram/hour prolonged-release vaginal ring Has manufactured dose form True Prolonged-release vaginal ring Inferred relationship Some

This concept is not in any reference sets

Back to Start